The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry

Autor: Annelie H. Musters, Conor Broderick, David Prieto‐Merino, Andrea Chiricozzi, Giovanni Damiani, Ketty Peris, Sandipan Dhar, Abhishek De, Esther Freeman, Bernd W. M. Arents, Tim Burton, Angela Leigh‐Ann L. Bosma, Ching‐Chi Chi, Godfrey Fletcher, Aaron M. Drucker, Kenji Kabashima, Emilie F. de Monchy, Maitreyee Panda, Dmitri Robert Wall, Christian Vestergaard, Emmanuel Mahé, Laura Bonzano, Leila Kattach, Maddalena Napolitano, María Fernanda Ordoñez‐Rubiano, Eva Haufe, Cataldo Patruno, Alan D. Irvine, Phyllis I. Spuls, Carsten Flohr

Publikováno v: Journal of the European Academy of Dermatology and Venereology. Wiley-Blackwell
Musters, A H, Broderick, C, Prieto-Merino, D, Chiricozzi, A, Damiani, G, Peris, K, Dhar, S, De, A, Freeman, E, Arents, B W M, Burton, T, Bosma, A L-A L, Chi, C-C, Fletcher, G, Drucker, A M, Kabashima, K, de Monchy, E F, Panda, M, Wall, D R, Vestergaard, C, Mahé, E, Bonzano, L, Kattach, L, Napolitano, M, Ordoñez-Rubiano, M F, Haufe, E, Patruno, C, Irvine, A D, Spuls, P I & Flohr, C 2023, ' The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis : Results from the global SECURE-AD registry ', Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, no. 2, pp. 365-381 . https://doi.org/10.1111/jdv.18613
Journal of the European Academy of Dermatology and Venereology, 37(2), 365-381. Wiley-Blackwell
Musters, A H, Broderick, C, Prieto-Merino, D, Chiricozzi, A, Damiani, G, Peris, K, Dhar, S, de, A, Freeman, E, Arents, B W M, Burton, T, Bosma, A L-A L, Chi, C-C, Fletcher, G, Drucker, A M, Kabashima, K, de Monchy, E F, Panda, M, Wall, D R, Vestergaard, C, Mahé, E, Bonzano, L, Kattach, L, Napolitano, M, Ordoñez-Rubiano, M F, Haufe, E, Patruno, C, Irvine, A D, Spuls, P I & Flohr, C 2022, ' The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis : Results from the global SECURE-AD registry ', Journal of the European Academy of Dermatology and Venereology . https://doi.org/10.1111/jdv.18613

BACKGROUND: Limited data are available on the effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis (AD).OBJECTIVE: To investigate COVID-19 outcomes in patients with AD treated with or without systemi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd54e9f71c0b428ac6e8b7e92aa3510a
https://pubmed.ncbi.nlm.nih.gov/36169355